Oral sodium bicarbonate reduces proximal renal tubular peptide catabolism, ammoniogenesis, and tubular damage in renal patients

Renal Failure

Volumn 20, Issue 2, 1998, Pages 371-382

  Rustom, Rana ^a   Grime, J Steve ^a   Costigan, Michael ^a   Maltby, Paul ^a   Hughes, Anthony ^a   Taylor, William ^a   Shenkin, Alan ^a   Critchley, Mair ^a   Bone, J Michael ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Royal Liverpool University Hospital ^*

Author keywords

Ammoniogenesis; Chronic renal failure; Protein catabolism; Sodium bicarbonate

Indexed keywords

APROTININ; BICARBONATE; EDETATE CHROMIUM CR 51; N ACETYL BETA GLUCOSAMINIDASE; TECHNETIUM 99M;

ACIDOSIS; ADULT; AMMONIA FORMATION; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DAMAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINURIA; URINARY EXCRETION; URINE PH;

EID: 0031924538     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045124     Document Type: Article

References (29)

1. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C: Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 65:1162-1173, 1980.
2. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265: E230-235, 1993.
3. Jenkins D, Burton PR, Bennett SE, Baker F, Walls J: The metabolic consequences of the correction of acidosis in uraemia. Nephrol Dial Transplant 4: 92-95, 1989.
4. Schrier RW, Harris DCH, Chan L, Shapiro JI, Caramelo C: Tubular hypermetabolism as a factor in the progression of chronic renal failure. Amer J Kid Dis 12:243-249, 1988.
5. Agarwal KA, Nath KA: Effect of proteinuria on renal interstitiium: Effect of products of nitrogen metabolism. Am J Nephrol 13:376-384, 1993.
6. El Nahas AM: Mechanism of progression and consequences of nephron reduction: In: Cameron S, Davison A, Grunfeld J-P, Kerr D, and Ritz E (eds); Oxford Textbook of Clinical Nephrology. Oxford University Press, 1992, 2, pp 1191-1227.
7. Nath KA, Hostetter MK, Hostetter TM: Pathophysiology of Chronic tubulointerstitial disease in rats. Interaction of dietary acid load, ammonia, and complement. J Clin Invest 79:667-675, 1985.
8. Tolins JP, Hostetter MK, Hostetter TH: Hypokalaemic nephropathy in the rat: The role of ammonia in chronic tubular injury. J Clin Invest 79:1447-1458, 1987.
9. Clark EC, Nath KA, Hostetter MK, Hostetter TH: Role of ammonia in progressive interstitial nephritis. Amer J Kid Dis 5:15-19, 1991.
10. Rustom R, Grime JS, Maltby P, Stockdale HR, Critchley M, Bone JM: A new method to measure renal tubular degradation of small filtered proteins in man using radio-labelled aprotinin (Trasylol). Clin Sci 83:289-294, 1992.
11. Rustom R, Grime JS, Maltby P, Stockdale HR, Critchley M, Bone JM: Observations of the early renal uptake and later metabolism of radiolabelled aprotinin in man: Theoretical and practical considerations. Clin Sci 84:231-235, 1993.
12. Rustom R, Grime S, Maltby P, Stockdale HR, Critchley M, Bone JM: Renal tubular degradation of radiolabelled Aprotinin (Trasylol) in chronic renal failure patients. Clin Sci 85:733-736, 1993.
13. 99mTc and urinary ammonia: Effects of proteinuria. J Miner Electrolyte Metab 18:108-12,1992.
14. Costigan M, Rustom R, Shenkin A, Bone JM: Origin and significance of urinary N-acetyl β-D-glucosaminidase (NAG), in renal patients with variable function, pathology and proteinuria Clinica Chimica Acta 255: 133-144, 1996.
15. Shibasaki T, Gorni H, Ishimoto F, Miyahara T: Urinary N-acetyl-beta-D-glucosaminidase isoenzyme activity as measured by fast protein liquid chromatography in patients with nephrotic syndrome. Clin Chem 36:102-103, 1990.
16. Maruhn D: Rapid colorimetric assay of galactoside and N-acetyl-glucosaminidase in human urine. Clin Chim Acta 73:453-461, 1976.
17. Watanabe N, Kamel S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K: Urinary protein as measured with pyrogallol red-molybdate complex. Manually and in a Hitachi 726 Automated Analyser. Clin Chem 32:1551,1986.
18. Bianchi C, Donadlo C, Tramonti G, Lorusso P, Bellitto L & Lunghi F: 99mTc-aprotinin: a new tracer for kidney morphology and function. Eur J Nucl Med 9: 257-260,1984.
19. 99mTc-aprotinin for the study of renal morphology and tubular function. Uraemia Invest 9:139-146, 1985/6.
20. Rustom R, Maltby P, Jackson MJ, Stockdale HR, Critchtey M, Bone JM: Renal tubular protein degradation and urinary ammonia in chronic renal failure. Nephrol Dial Transplant 7: 153, 1992.
21. Schoolwerth AC, Sandler RS, Hoffman PM, Klahr S: Effects of nephron reduction and dietary protein content on renal ammoniagenesis in the rat. Kidney Int 7:397-404, 1975.
22. Tizianello A, De Ferrari G, Garibotto G, Gurreri G: Effects of clinical renal insufficiency and metabolic acidosis on glutamine metabolism in man. Clin Sci 55:391-397, 1978.
23. Rustom R, Costigan M, Shenkin A, Bone JM: Proteinuria and renal tubular damage: urinary N-acetyl-β-D-glucosaminidase (NAG) and isoenzymes in dissimilar renal diseases. Amer J Nephrol (in press), 1997.
24. Rustom R, Bone JM: Effects of oral sodium bicarbonate on urinary ammonia excretion in chronic renal failure (CRF). Nephrol Dial Transplant 8:940, 1993.
25. Maack T, Hyung P, Camargo MJF: Renal filtration, transport, and metabolism of proteins. In: Seldin, Giebisch, (eds); The Kidney: Physiology and Pathophysiology. New York, Raven Press, 1985, pp 1773-1803.
26. Rustom R, Maltby P, Grime JS, Stockdale HR, Critchley M, Bone JM: Effects of lysine infusion on renal aprotinin metabolism in man. Clin Sci 83:295-299, 1992.
27. Throssell D, Brown J, Harris KPG, Walls J: Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci 89:643-650, 1995.
28. Price RG: The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagposis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 38:S14-S19, 1992.
29. Kaysen GA, Bander HL: Metabolism of albumin and immunoglobulins in the nephrotic syndrome. Am J Nephrol 10 (suppl 1):36-42, 1990.